Characterization of the non-competitive antagonist binding site of the NMDA receptor in dark Agouti rats

Life Sciences

Volumn 75, Issue 12, 2004, Pages 1405-1415

  Sun, WenLin ^a   Wessinger, William D ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Dark Agouti rats; Dizocilpine; MK 801; NMDA receptor; Non competitive NMDA antagonists; Receptor binding; Strain comparison

Indexed keywords

DEXOXADROL; DEXTROMETHORPHAN; DEXTRORPHAN; DIZOCILPINE; ION CHANNEL; KETAMINE; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; FEMALE; ISOTOPE LABELING; NONHUMAN; RAT; RECEPTOR AFFINITY;

ANIMALS; BINDING, COMPETITIVE; BRAIN; DEXTROMETHORPHAN; DIOXOLANES; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; KETAMINE; N-METHYLASPARTATE; PHENAZOCINE; PHENCYCLIDINE; PIPERIDINES; RATS; RATS, MUTANT STRAINS; RECEPTORS, N-METHYL-D-ASPARTATE; SCINTILLATION COUNTING; TRITIUM;

AGOUTI;

EID: 3042700112     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.11.035     Document Type: Article

References (31)

1. Banerji S., Anderson I.B. Abuse of Coricidin HBP Cough & Cold tablets: episodes recorded by a poison center. American Journal of Health-System Pharmacists. 58:2001;1811-1814
2. Barnhart J.W. The urinary excretion of dextromethorphan and three metabolites in dogs and humans. Toxicology and Applied Pharmacology. 55:1980;43-48
3. Bem J.L., Peck R. Dextromethorphan. An overview of safety issues. Drug Safety. 7(3):1992;190-199
4. 3H]MK-801 binding to well-washed rat brain membranes following cessation of chronic phencyclidine treatment. Pharmacology Biochemistry and Behavior. 51(2/3):1995;435-438
5. Chaplan S.R., Malmberg A.B., Yaksh T.L. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. Journal of Pharmacology and Experimental Therapeutics. 280(2):1997;829-838
6. 50) of an enzymatic reaction. Biochemical Pharmacology. 22:1973;3099-3108
7. Deutsch S.I., Rosse R.B., Mastropaolo J. Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice. Clinical Neuropharmacology. 20(5):1997;375-384
8. 3H]dextrorphan binding in rat brain is localized to a noncompetitive antagonist site of the activated N-methyl-D-aspartate receptor-cation channel. Molecular Pharmacology. 41:1992;134-146
9. Hartgraves M.D., Fuchs J.L. NMDA receptor binding in rodent suprachiasmatic nucleus. Brain Research. 640(1-2):1994;113-118
10. 2+ channels. Neuroscience Letters. 105:1989;227-232
11. Kamei J., Iwamoto Y., Misawa M., Kasuya Y. Effects of rimcazole, a specific antagonist of σ sites, on the antitussive effects of non-narcotic antitussive drugs. European Journal of Pharmacology. 242:1993;209-211
12. Kenakin T. Molecular Pharmacology: A Short Course. 1977;Blackwell Science, Cambridge, MA
13. Kotzer C.J., Hay D.W.P., Dondio G., Giardina G., Petrillo P., Underwood D.C. The antitussive activity of δ-opioid receptor stimulation in guinea pigs. Journal of Pharmacology and Experimental Therapeutics. 292(2):2000;803-809
14. Küpfer A., Schmed B., Pfaff G. Pharmacogenetics of dextromethorphan O-demethylation in man. Xenobiotica. 16:1986;421-433
15. Larrey D., Distlerath L.M., Dannan G.A., Wilkerson G.R., Guengerich F.P. Purification and characterization of the rat liver microsomal P-450 involved in the 4-hydroxylation of debrisoquine, prototype for genetic variation in oxidative drug metabolism. Biochemistry. 23:1984;2787-2795
16. Liljequist S. Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice. Psychopharmacology. 104(1):1991;17-21
17. Matsunaga E., Zanger U.M., Hardwick J.P., Gelboin H.V., Meyer U.A., Gonzalez F.J. The CYP2D gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry. 28(18):1989;7349-7355
18. Motulsky H.J. Analyzing Data with GraphPad Prism. 1999;GraphPad Software Inc. San Diego, CA
19. Newman A.H., Shah J.H., Izenwasser S., Heller B., Mattson M., Tortella F.C. Highly selective σ1 ligands based on dextromethorphan. Medicinal Chemistry Research. 6:1996;102-117
20. Plesan A., Hedman U., Xu X.J., Wiesenfeld-Hallin Z. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rats. Anesthesia and Analgesia. 86(4):1998;825-829
21. 3H]dextrorphan binding sites in rat brain determined by quantitative autoradiography. Journal of Pharmacology and Experimental Therapeutics. 277(3):1996;1823-1836
22. Soucek P., Gut I. Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica. 22(1):1992;83-103
23. Tortella F.C., Pellicano M., Bowery N.G. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends in Pharmacological Sciences. 10(12):1989;501-507
24. 3H]TCP) binding properties to rat and human brain membranes. Life Sciences. 45(26):1989;2547-2555
25. Vu T.H., Weissman A.D., London E.D. Pharmacological characteristics and distributions of σ- and phencyclidine receptors in the animal kingdom. Journal of Neurochemistry. 54(2):1990;598-604
26. Wessinger W.D. Sexual dimorphic effects of chronic phencyclidine in rats. European Journal of Pharmacology. 277:1995;107-112
27. 3H]MK-801 binding by noncompetitive NMDA receptor antagonists in dark Agouti rat brain membranes. Drug and Alcohol Dependence. 66(Suppl. 1):2002;S193
28. 3H]MK-801 binding in long-sleep and short-sleep lines of mice. Alcohol. 13(3):1996;315-320
29. Wong E.H.F., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proceedings of the National Academy of Sciences, U.S.A. 83:1986;7104-7108
30. 3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. Journal of Neurochemistry. 50:1988;274-281
31. Xu X., Domino E.F. Genetic differences in the locomotor response to single and daily doses of phencyclidine in inbred mouse strains. Behavioural Pharmacology. 5(6):1994;623-629